Annexon, Inc.
NASDAQ:ANNXBiotechnology
-$0.04 today
- Market cap
- $576.73M
- Beta
- 1.18
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$1.01
Volume 2.98M
Average 2.56M
ANNX Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Annexon, Inc.NASDAQ: ANNX
Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026
Weighted avg shares (diluted) growth accelerates
Q1 FY2026 weighted avg shares (diluted) of 194.2M shares rose 31.1% year over year, ahead of the +14.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 25.2% from the prior quarter. Over 3 fiscal years it compounded at +41.6% a year.
Context
- Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +31.1% holds above the trailing-twelve-month pace of +14.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 155.11M USD
- Year-over-year change
- +12.9%
- 4-year CAGR
- +41.8%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 155.11M | +12.9% |
| FY2024 | 2024-12-31 | 137.4M | +81.6% |
| FY2023 | 2023-12-31 | 75.67M | +38.4% |
| FY2022 | 2022-12-31 | 54.67M | +42.7% |
| FY2021 | 2021-12-31 | 38.32M | — |
Weighted Avg Shares (Diluted) vs competitors
How ANNX compares with its peers on the latest reported figures
- ANNX's LTM Mar 2026 weighted avg shares (diluted) of 161.69M shares is the 2nd highest of the 11 companies compared; the peer median is 72.23M shares.
- Its year-over-year change of +14.3% is the 5th highest of 11, against a peer median of +7.9%.
- Over three fiscal years its annual growth of +41.6% compares with a peer median of +14.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | 199.36M | +24.0% | +14.0% | |
| LTM Mar 2026 | 161.69M | +14.3% | +41.6% | |
| LTM Mar 2026 | 124.17M | +37.8% | +23.4% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | 115.39M | +93.6% | +384.0% |
| LTM Mar 2026 | 99.9M | -0.5% | +6.4% | |
| LTM Jun 2026 | 74.94M | +5.1% | +7.6% | |
| FY2025 | 69.53M | +10.3% | +53.9% | |
| LTM Mar 2026 | 68.86M | +14.8% | +15.0% | |
| LTM Mar 2026 | 53.9M | -0.4% | +4.4% | |
| LTM Mar 2026 | 29.47M | +0.4% | +3.6% | |
| LTM Mar 2026 | 12.78M | +5.6% | +56.9% | |
| Peer median (excluding ANNX) | 72.23M | +7.9% | +14.5% | |
Competitors are the stored peer set for ANNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 3.45M | 3.69M |
| Gross Profit | 0 | 0 | 0 | (3.45M) | (3.69M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 100.07M | 112.5M | 113.76M | 119.45M | 184.7M |
| Selling, General & Admin | 30.65M | 30.95M | 28.02M | 34.63M | 31.71M |
| Operating Expenses | 130.71M | 145.6M | 143.72M | 150.62M | 212.72M |
| Depreciation & Amortization | 2.14M | 2.15M | 2.15M | 3.45M | 2.65M |
| EBITDA | (128.18M) | (139.8M) | (132.09M) | (134.75M) | (204.04M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (130.71M) | (145.6M) | (143.72M) | (154.07M) | (216.41M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 390K | 3.65M | 9.49M | 15.87M | 9.72M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 390K | 3.65M | 9.49M | 15.87M | 9.72M |
| Income Before Tax | (130.32M) | (141.95M) | (134.24M) | (138.2M) | (206.69M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (130.32M) | (141.95M) | (134.24M) | (138.2M) | (206.69M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (3.34) | (2.60) | (1.77) | (1.01) | (1.34) |
| EPS (Diluted) | (3.34) | (2.60) | (1.77) | (1.01) | (1.34) |
| Weighted Avg Shares | 38.32M | 54.67M | 75.67M | 137.4M | 155.11M |
| Weighted Avg Shares (Diluted) | 38.32M | 54.67M | 75.67M | 137.4M | 155.11M |
Annexon, Inc.
NASDAQ:ANNX
Intrinsic Alpha fair value
Locked
Current Price
$3.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.